Cholesterol, Synaptic Function and Alzheimer’s Disease

We experimentally modeled neuronal cholesterol imbalance by creating an acute biochemical increase in cholesterol turnover in rat hippocampal slices. This kind of experimental set-up impairs the redistribution of cholesterol from one cell to another via lipoprotein transport. While increasing cholesterol removal or immediately afterwards, we evoked and recorded two brain waveforms, paired pulse facilitation (PPF) and long-term potentiation (LTP), which indicate neurotransmission and synaptic plasticity, respectively. We found that the lack of cholesterol supply to neurons impaired both PPF and LTP. From additional immunofluorescent analysis of the slices, we could demonstrate that the cholesterol imbalance also caused neurodegeneration of hippocampal neural cell processes and the appearance of tau protein pathology in the mossy fibers. We also analyzed rats fed a cholesterol diet and discovered that they had increased hippocampal cholesterol biosynthesis and impaired LTP. Cholesterol-fed rats were also characterized by Alzheimer’s-like brain amyloid that we did not observe in the model of acute cholesterol imbalance. Our data and research by others suggest that biological cholesterol homeostasis dysregulation itself plays a key role in synaptic plasticity impairment and neuronal degeneration, and is the primary cause for several Alzheimer’s disease hallmarks not limited to brain amyloids. Moreover, changes in the neurochemistry of amyloid beta, tau, neuronal cytoskeleton, and oxidative stress reactions due to Alzheimer’s likely represent physiological transitory mechanisms that aim to compensate impaired brain cholesterol dynamics and/or associated neurotransmission and synaptic plasticity failure.

Part of this article was published as netprint and is available under the URL http://clinmed.netprints.org/cgi/content/full/2001100005v1 .

References

• 1 Auerbach J M, Segal M. Peroxide modulation of slow onset potentiation in rat hippocampus.  J Neurosci.. 1997;  17 8695-8701
• 2 Berezov T T, Koudinov A R. Is oxidative stress pathway a physiologic modulator for neural plasticity? 13th Meeting of the European Neurological Society. Istanbul June 14 - 18, 2003, Abstract book,: P685
• 3 Brion J P, Couck A M, Conreur J L, Octave J N. A phosphorylated tau species is transiently present in developing cortical neurons and is not associated with stable microtubules. In: Kosik KS, Christen Y, Selkoe DJ, eds Alzheimer’s Disease: Lessons from Cell Biology. Berlin Heidelberg; Springer-Verlag 1995: p.150-171
• 4 Brown M S, Goldstein J L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.  Cell. 1997;  89 331-340
• 5 Champagne D, Rochford J, Poirier J. ApoE and LDL receptor knockout mice display acquisition deficits in the Morris water maze.  Soc Neurosci Abstr. 2000;  26 1546
• 6 Chen G, Chen K S, Knox J. et al . A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer’s disease.  Nature. 2000;  408 975-979
• 7 Chochina S V, Avdulov N A, Igbavboa U, Cleary J P, O’Hare E O, Wood W G. Amyloid beta-peptide(1 - 40) increases neuronal membrane fluidity. Role of cholesterol and brain region.  J Lipid Res. 2001;  42 1292-1297
• 8 Crews F T, Camacho A, Philips M I. Cholinergic stimulation of hippocampal pyramidal cells is inhibited by increasing membrane cholesterol.  Brain Res. 1983;  261 155-158
• 9 Demeester N, Castro G, Desrumaux C. et al . Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer’s disease.  J Lipid Res. 2000;  41 963-974